Why Navidea Biopharmaceuticals Shares Are Nosediving
Why Navidea Biopharmaceuticals Shares Are Nosediving
Navidea Biopharmaceuticals Inc (NASDAQ:NAVB) shares are trading lower by 18.5% to $0.08 after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.
Navidea 生物製藥公司 納斯達克股票代碼：NAVB）宣佈後，股價下跌18.5％，至0.08美元 紐約證券交易所美國分所 已啓動除牌程序，該公司打算提出上訴。
Navidea's Board of Directors plans to appeal the decision. During the appeal, the common stock will continue to be listed and traded on NYSE American.
Navidea董事會計劃對該決定提出上訴。在上訴期間，普通股將繼續在紐約美國證券交易所上市和交易。
The company says there can be no assurance that Navidea's request for continued listing will be granted.
該公司表示，無法保證Navidea的繼續上市請求會獲得批准。
If delisted, Navidea intends to quote its common stock in the over-the-counter market.
如果退市，Navidea打算在場外交易市場報價其普通股。
See Also: Why AerCap Shares Are Rising Today
另見：爲什麼 AerCap 的股價今天上漲
According to data from Benzinga Pro, NAVB has a 52-week high of $0.65 and a 52-week low of $0.07.
根據Benzinga Pro的數據，NAVB創下52周高點爲0.65美元，52周低點爲0.07美元。
譯文內容由第三人軟體翻譯。